Patients diagnosed with (muscle-) invasive bladder cancer (IBC) are more likely to harbour comorbidities due to their advanced age at diagnosis. Under-nutrition is a predictor for postoperative morbidity and mortality in cancer patients, but under-reported in urology. Understanding the IBC patient profile before major surgery could facilitate and optimise outcome of the surgical patient. BACKGROUND/OBJECTIVES: To identify preoperative risk factors for early rehabilitation before radical cystectomy (RC). SUBJECTS/METHODS: A historical registry-based study of 76 patients referred for RC at Aarhus University Hospital, Denmark (DK) in 2009. Early rehabilitation was defined by length of stay (LOS) postoperatively with a cutoff p11 days. High comorbidity was expressed by the charlson comorbidity index score (CCI) X3. LOS was calculated by linking the unique Civil Registration Number with the National Patient Registry. Preoperative nutritional risk was identified using the screening tool, nutritional risk score 2002 (NRS) of the European Society of Clinical Nutrition and Metabolism. Multivariate analysis was used to identify risk factors for early rehabilitation. RESULTS: The proportion of patients at preoperative nutritional risk was 26% (95% confidence interval (CI): (95% CI: 17; 37) and 43% of patients held a high CCI (95% CI: 33; 55). Prolonged LOS was independently associated with female gender (P ¼ 0.02) and age X70 years (P ¼ 0.04). NRS and CCI were not associated with LOS. CONCLUSIONS: Attention should be focused on women and elderly patients undergoing RC to optimise early rehabilitation and reduce LOS. It is still unknown whether preoperative nutritional risk and comorbidity are obstacles in early rehabilitation of RC patients.
INTRODUCTION
Patients with muscle invasive bladder cancer (IBC) often harbour comorbidities because of their advanced age at diagnosis and their smoking habits. 1, 2 Regardless of age, radical cystectomy (RC) is the standard treatment for IBC. 3, 4 Surgical outcomes following RC are usually described by mortality, rate of complication or the generic term 'early rehabilitation,' which is often measured by length of stay (LOS). [1] [2] [3] Comorbidity is associated with a high complication rate and prolonged LOS in patients after RC surgery. 1, 4 However, little is known about other predictors of early rehabilitation in IBC patients. 1, 3, 5 Up to 50% of patients undergoing cancer surgery are reported to be undernourished; this is a clinical predictor of postoperative morbidity and mortality following cancer surgery. 4, [6] [7] [8] Under-nutrition is associated with loss of muscle strength and a depressed immune system, while surgery can precipitate pain, nausea, vomitting, ileus and stressinduced catabolism. 5, 6, 9 These problems can lead to complications and delayed recovery. [10] [11] [12] The concept of fast-track pathways has become standard procedure in many surgical settings to enhance postsurgical recovery. [13] [14] [15] Development of safe and short-acting anaesthetics improved postoperative pain management, and multimodal pre-, peri-and postoperative interventions have provided important possibilities for enhanced recovery and a decrease in LOS. [16] [17] [18] However, implementation of the concept is lacking 15 and the impact of preoperative modifiable risk factors such as nutritional risk and comorbid status has been incompletely explored in bladder cancer pathways, 2, 3, 5, 19, 20 thus the preoperative patient profile in IBC patients before surgery is not well understood. Knowledge concerning the preoperative patient status may facilitate patient-tailored interventions to optimise the postoperative surgical patient journey. 21 Postoperative patient outcome could potentially be improved by early nutritional screening with adequate and timely preoperative support. 6, 9, 22 The aim of this study was to investigate the prevalence of under-nutritional risk and comorbidity in an IBC population before RC and to identify risk factors for early rehabilitation.
patients received the International Classification of Diseases 10-code for IBC (C69), were referred to Aarhus University Hospital, DK in 2009 and were surgically treated with RC. Patients were identified in the Danish National Patient Registry. 23 A total of 82 cystectomies were performed. Six of these patients were subsequently excluded because of non-malignant diagnosis. The male/ female ratio was 3/1, including 57 men (n 0 ) and 19 women (n 1 ), respectively. All data were sampled before implementing fast-track strategies in RC pathways.
Outcome and outcome measurement LOS was defined as a proxy for early rehabilitation and expressed as the number of days from surgery to discharge. A cutoff of p11 days was chosen for early rehabilitation as the median LOS in 2009 was 11 days and the average was 11.3 days (Table 1) . Comorbidity was quantified by the validated charlson comorbidity index score (CCI) consisting of 19 medical conditions weighted according to their potential influence on mortality. 24 The score predicts short-and long-term mortality and outcome in cancer patients. The patients were classified according to the index score: (a) patients with score 0 (no), (b) patients with score 1-2 (low), (c) patients with score 3-4 (high) and (d) patients with score X5 (severe) comorbidity and for later analysis dichotomised at an index score at 2 or less as low and X3 as high comorbidity. 1 Nutritional risk was calculated using the age-adjusted nutritional risk score (NRS), which combines indicators of under-nutrition and severity of disease defined by The European Society for Clinical Nutrition and Metabolism. 7, 25, 26 Severity of nutritional status and severity of disease were scored between 0 and 3 points, respectively. Another point was added for age above 70 years. NRS is expressed as an age-adjusted score of 0-7 points with 7 points as the highest possible risk score. Patients receiving a total risk score of three points or higher were considered at risk. 25 A cutoff was defined when patients were considered at risk with a NRS of X3. Other covariates such as age, gender, urinary-diversion type, tumour stage, smoking and marital status were obtained from medical records.
Data sources
Multiple database linkages were performed using the unique Danish Civil Registration Number. The National Patient Registry was established in 1977 and includes data from nearly all hospital admissions in Denmark. The National Danish Cancer Registry includes data on all person diagnosed with cancer in the Danish population since 1942. Linkage of data by the Civil Registration System is accurate ensuring a high validity. 27, 28 Linking the IBC patients' unique Civil Registration Number with the National Patient Registry identified information concerning LOS and comorbidity status. 29 
Statistics
Demographic and clinical variables were reported with descriptive statistics. The Pearson two-sided w 2 -test was used to test for differences between proportions. Multivariate analysis was performed to investigate any possible associations between LOS and covariates and reported with an odds ratio (OR) and 95% confidence interval (CI).The likelihood ratio test was used to test for any interaction. The multivariate model fit was tested with the 'Goodness of Fit' Test.
Ethics
Covariates were extracted after approval from the Institutional Review Board. Authority to register the data was given by the National Danish Data Protection Agency (J.Nbr.2010-41-4306). 30 No permission was needed from the local ethics committee, as analyses were based on registry data and medical records, clinical management and safety were not compromised and did not require patient consent. To ensure anonymity patient data were encrypted. Table 1 . The average LOS was 11.3 days (s.d. 4 .95) and the median was 11 days ranging from 4-37 days. Women were on average hospitalised 1.66 days longer than men (P ¼ 0.2), whereas early rehabilitation defined as p11 days was achieved in 42% compared with 77% in men (Po0.05) ( Table 1 ). The preoperative tumour burden was evenly distributed between genders. According to the NRS, 26% of the patients were considered at nutritional risk before surgery and 43% were considered to have a high to severe CCI (X3) according to definition; no other differences were found between genders apart from postoperative LOS (Table 1) . Table 2 elucidates the distribution of the CCI with respect to the increasing weight of the integrated diseases. The most frequent comorbidity was myocardial infarction, peripheral vascular disease, chronic obstructive pulmonary lung disease and renal disease.
RESULTS

Patient characteristics are presented in
Performing a logistic regression model with dichotomized LOS as the dependent variable including NRS, CCI, age-groups and gender showed an independent statistical association between prolonged LOS and female gender compared with men (OR 4.65 95% CI: 1.2; 9.6). Moreover, being older was associated with prolonged LOS (411 days). There were no significant associations between LOS and NRS or LOS and the comorbidity index score, respectively. The likelihood ratio test showed no evidence of interaction (Table 3) .
DISCUSSION
In this registry-based study we found that older age and female gender were independently and significantly associated with prolonged LOS. These findings warrant clinical attention. The existing literature reports increased complications with advanced age following RC, impeding successful rehabilitation and causing prolonged LOS. 31 A Canadian study reported age X80 years should be considered in clinical decision making with respect to survival and clinical and pathological outcomes. 32 In contrast, a recent review concluded that age alone does not preclude RC, but in geriatric patients the procedure requires careful evaluation and excellent perioperative care, which may then prevent postoperative morbidity. 21 Bladder cancer most commonly occurs beyond 70 years of age and prevalence increases with age. 21 Consequently, treatment decisions for elderly patients with IBC or recurrent bladder cancer will constitute an important clinical challenge in the future as the population ages.
1,21 Currently, it is not possible to identify or define an age or comorbidity limit that precludes radical treatment. 2, 21, 33 With respect to these findings, the cutoff value for age in this study was based on international documentation that IBC peaks about the age of 70 years 1, 21, 34 and this was in line with the age cutoff in the NRS screening tool used in this study. In this study, we found no statistically significantly difference between men and women regarding the preoperative patient profile (Table 1) . A difference in LOS of 1.66 days on average between men and women was observed, but was imprecisely measured. However, when categorising LOS due to definition of early rehabilitation a significant difference was observed ( Table 1) . The multivariate regression analysis showed female gender was significantly associated with prolonged LOS (Table 3) . A recent published review emphasised disparities between genders and reported women with IBC to suffer delays in diagnosis and have more advanced tumours than men at time of diagnosis. 35 In another study, it was reported that being a woman was associated with greater blood loss, transfusion requirements and intensive care needs although the overall LOS was similar between genders. 36 In Table 1 it can be seen that the tumour burden (non-organ vs organ-confined) between genders was even. This may either be due to the small sample size, lower incidence of IBC in women in general, or that all socioeconomic classes have the same access to healthcare in Denmark. The latter differs from other countries such as the USA. 31, 33, 36 Danish men and women are possibly diagnosed at the same tumour stage in contrast to findings in other studies. 35 In summary, clinical practice may be improved by increased awareness to gender differences preoperatively. Surprisingly, comorbidity did not significantly influence LOS in our study although nearly half of the RC sample (43%) was classified with a high to severe comorbidity index score (Table 1) . This is in contrast to other findings where preoperative comorbidity was considered to be related to the discharge decision. 31, 37 Subgroups may have postoperative care needs that may be appropriate targets for preoperative planning. 37 However, the proportion of 43% with a high degree of comorbidity clearly describes the fragile status of patients with advanced bladder cancer regardless of their LOS. The clinical importance of the comorbidity index score in this study is that old patients or relatively very sick young patients could be candidates for surgery and not automatically excluded from this stressful intervention.
2,33 A recent study from Canada suggested that age X80 years was independently associated with survival but was not adjusted for comorbidity. 32 Elderly patient's X80 years could be good candidates for radical treatment, whereas the same treatment may be risky for severely comorbid younger patients. 2, 21, 33 Decision management in clinical practice is very complex and a more proactive approach targeting individual performance before surgery may be of future interest. Charlson comorbidity index score, which consists of 19 medical conditions weighted according to their potential influence on mortality. The patients were classified according to the index score: (a) patients with score 0 (no), (b) patients with score 1-2 (low), (c) patients with score 3-4 (high) and (d) patients with score X5 (severe) comorbidity and for later analysis dichotomised at a index score o3 as low and X3 as high comorbidity. We found a quarter of our patients were at nutritional risk preoperatively (NRS X3), which is similar to another two studies using a version of the NRS 2002 designed specifically for urology patients. These studies found that in malignant patients, 24% of the women and 19% of the men were at nutritional risk. 3, 19 We did not find a significant association between preoperative nutritional risk and LOS to support a strategy for an extended preoperative effort. However, only a few studies in uro-oncology have challenged the role of preoperative nutritional risk assessment and related patient outcome in advanced bladder cancer surgery. 3, 11, 39 These studies have used different methods and patient outcomes making comparison of our results difficult. However, Johansen et al. 9 found that LOS was significantly higher in patients at preoperative nutritional risk. Unfortunately, the study was not conducted in a specific urological population. In relation to European Society of Clinical Nutrition and Metabolism guidelines the information achieved in this study is valuable for clinical practice. Major surgery is recommended to be postponed until sufficient nutritional status is achieved in order to reduce postoperative complications and mortality and hence optimise rehabilitation. 2, 3, 19, 40 On the basis of European Society of Clinical Nutrition and Metabolism and the information gathered in the present study (with respect to limitations) timely preoperative evaluation including nutritional care plan and oral supplements before surgery should be considered when establishing and standardising future prevention strategies in RC pathways.
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Limitations
The mean LOS of 11.3 days in this study is relatively high compared to other studies with an observed mean LOS between 5 and 8 days. 39, 41 One European study reported a LOS 15 days. 10 However, LOS may vary for many reasons and might be unique to different centres due to sub-cultures, different referral patterns, differences in health-care system, surgical protocols and possibly different access to homecare support. 35 Therefore, LOS may not be an acceptable comparative outcome measure but may primarily be useful for administrative purposes. Using a set of clear discharge criteria will support the necessity of this parameter, but other parameters should be considered to define early rehabilitation.
All available data of patients undergoing RC during the study period were included. However, the wide CIs related to the observed results in Table 3 suggest the precision of the estimate has potential for improvement for example, by increasing the sample size. Given the nature of the design, this study did not offer the possibility of pretrial power considerations. Thus, our clinical observed results must be interpreted with respect to the CI and the size of the study cohort.
CONCLUSION
This study highlights the preoperative burden of comorbidity and nutritional risk among patients undergoing RC. Concerning early rehabilitation, female gender and advanced age were independently associated with prolonged LOS.
However, possibly due to the relatively small sample size and nature of the study design, no associations were identified between LOS and preoperative NRS or CCI.
To optimise early rehabilitation and patient outcomes in RC pathways, future prospective studies are needed. Increased attention to early evaluation and targeted treatment of risk factors in RC may improve postoperative recovery.
